EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis: a preliminary study

Nils Schulz, Gabriel Dischereit, Laura Henke, Uwe Lange, Philipp Klemm

Clinical and Experimental Medicine · 2024

DOI: 10.1007/s10238-024-01385-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Nils Schulz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus-Liebig-University Giessen, Campus Kerckhoff, Benekestr. 2-8,…. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Scleroderma, Systemic, Bone Density. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with systemic sclerosis (SSc) have a disproportionately high prevalence of reduced bone mineral density (BMD). Polymorphisms of the vitamin D receptor (VDR) gene have been associated with osteoporosis in patients with autoimmune diseases. The aim of this study was to investigate the prevalence and possible effects of VDR polymorphism on BMD and bone metabolism in patients with SSc. In patients with SSc measurement of BMD was performed using dual-energy X-ray absorptiometry. VDR polymorphisms (FokI, BsmI) were genotyped using restriction fragment length polymorphism analysis. Markers of bone metabolism (calcium, osteocalcin, β-crosslaps) were determined. Primary endpoint was the prevalence of VDR gene polymorphisms and the association with reduced BMD. Secondary endpoints included associations between bone metabolism and VDR gene polymorphism. 79 Caucasian patients with SSc were included. Overall, 83.5% had reduced BMD (51.9% osteopenia, 31.6% osteoporosis). The prevalence of VDR gene polymorphism (73% BsmI, 77% FokI) was comparable to studies in healthy and rheumatic populations. The homozygous presence of FokI polymorphism, but not BsmI, was significantly associated with reduced axial BMD. Fokl polymorphism was significantly associated with reduced CTX levels, although changes remained within the reference limits. VDR polymorphisms can frequently be found in patients with SSc in comparable prevalence to healthy and rheumatic populations. The homozygous presence of FokI polymorphism, but not BsmI, was significantly associated with reduced axial BMD. This could be a possible contributor for the high prevalence of reduced BMD in 83.5% of patients with SSc in this study. Trial registration . DRKS00032768, date: 05.10.2023, retrospectively registered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolScleroderma, SystemicBone DensityHumansFemaleMaleMiddle AgedAgedAdultPrevalenceOsteoporosisAbsorptiometry, PhotonPolymorphism, GeneticPolymorphism, Restriction Fragment LengthBone Diseases, MetabolicGenotype

Stichwörter der Autor:innen

Bone mineral densitySystemic sclerosisVDR polymorphisms

Substanzen

Receptors, CalcitriolVDR protein, human

Autor:innen und Institutionen

  • Department of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus-Liebig-University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany. n.schulz@kerckhoff-klinik.de.
  • Department of Rheumatology, Clinical Immunology, Osteology and Physical Medicine, Justus-Liebig-University Giessen, Campus Kerckhoff, Benekestr. 2-8, 61231, Bad Nauheim, Germany.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Schulz, N., Dischereit, G., Henke, L., Lange, U., & Klemm, P. (2024). Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis: a preliminary study. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01385-1

Vancouver

Schulz N, Dischereit G, Henke L, Lange U, Klemm P. Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis: a preliminary study. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01385-1

BibTeX
@article{Schulz2024,
  author = {Schulz, Nils and Dischereit, Gabriel and Henke, Laura and Lange, Uwe and Klemm, Philipp},
  title = {Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis: a preliminary study},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.1007/s10238-024-01385-1}
}
Kostenlos starten →